A systematic review of biomarkers for disease progression in Parkinson's disease

Background: Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may he http://t.co/TlxGgeALMQ

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/TlxGgeALMQ